Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Masteryourmoney Earnings
moneycontrol.com

Home » News » Announcements

Jul 22, 2013, 03.48 PM | Source: Moneycontrol.com

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.

Like this story, share it with millions of investors on M3

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.

Post Your Comments

Share Cancel

Lupin Ltd has informed BSE regarding a Press Release dated July 22, 2013, titled "Lupin receives FDA approval for Generic GIumetza extended-release Tablets" Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.Source : BSE

Read all announcements in Lupin

To read the full report click here

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Lupin receives FDA approval for Generic GIumetza extended-release tablets

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login